Current advances and challenges of mesenchymal stem cells-based drug delivery system and their improvements

Yuanqin Su,Tianyuan Zhang,Ting Huang,Jianqing Gao
DOI: https://doi.org/10.1016/j.ijpharm.2021.120477
IF: 6.51
2021-01-01
International Journal of Pharmaceutics
Abstract:Mesenchymal stem cells (MSCs) have recently emerged as a promising living carrier for targeted drug delivery. A wealth of literature has shown evidence for great advances in MSCs-based drug delivery system (MSCs-DDS) in the treatment of various diseases. Nevertheless, as this field of study rapidly advances, several challenges associated with this delivery strategy have arisen, mainly due to the inherent limitations of MSCs. To this end, several novel technologies are being developed in parallel to improve the efficiency or safety of this system. In this review, we introduce recent advances and summarize the present challenges of MSCs-DDS. We also highlight some potential technologies to improve MSCs-DDS, including nanotechnology, genome engineering technology, and biomimetic technology. Finally, prospects for application of artificially improved MSCs-DDS are addressed. The technologies summarized in this review provide a general guideline for the improvement of MSCs-DDS.
What problem does this paper attempt to address?